Christopher J. Jowett

Christopher J. Jowett has a diverse and extensive work experience in the biopharma and medical industry. Christopher J. currently holds the position of Business Development, Global Biopharma Oncology at Pillar Biosciences Incorporated since February 2023.

Prior to that, from June 2021 to August 2022, they served as the Chief Commercial Officer (CCO) at Visby Medical.

From March 2018 to June 2021, Jowett worked at QIAGEN as the Vice President Sales, Molecular Diagnostics.

Before joining QIAGEN, they worked as the Chief Operations Officer at Analyte Health from January 2016 to March 2018.

Jowett has a long history with Abbott Labs and its subsidiaries. Christopher J. held various roles at Abbott Molecular Inc., including Global Head, Oncology & Genetics Franchise; Global Head, Companion Diagnostics; General Manager, Commercial Operations; Sr. Director of Commercial Operations, U.S. & Canada; Director of Sales, U.S.; Director of Marketing; and Global Marketing Manager for Infectious Disease.

Prior to joining Abbott Molecular Inc., they worked at Abbott Diabetes as an Area Sales Manager from April 2000 to April 2002.

Jowett began their career at Abbott Labs as a Product Manager PCx, a role they held from 1998 to 2000.

Christopher J. Jowett holds a Bachelor of Science degree in Medical Technology from Michigan State University. The exact start and end year of their enrollment at the university is not provided.